Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 4 | The Journal of Headache and Pain

Fig. 4

From: Gamma-aminobutyric acid and glutamate/glutamine levels in the dentate nucleus and periaqueductal gray in new daily persistent headache: a magnetic resonance spectroscopy study

Fig. 4

Correlation between clinical characteristics and neurotransmitter levels. (A) Negative correlation between Glx/Water in the PAG and the VAS score (r=-0.471, p = 0.031, n = 21). (B) Negative correlation between Glx/Water in the DN and the VAS score (r=-0.501, p = 0.021, n = 21). (C) Negative correlation between Glx/Cr in the DN and the VAS score (r=-0.483, p = 0.026, n = 21). (D) Positive correlation between GABA+/Water in the DN and the GAD-7 score (r = 0.519, p = 0.039, n = 16). Gray shading represents the 95% confidence intervals of the partial correlations. PAG, periaqueductal gray; DN, dentate nucleus; Cr, creatine; GABA, gamma-aminobutyric acid; Glx, glutamate/glutamine; VAS, Visual analog scale; GAD-7, Generalized Anxiety Disorder-7

Back to article page